Press release
Deadline on October 28th coming up in Lawsuit for Investors in Outset Medical, Inc. (NASDAQ: OM)
A Deadline is coming up on October 28, 2024 in the lawsuit for certain investors in Outset Medical, Inc. (NASDAQ: OM).
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and there are strict and short deadlines running. Deadline: October 28, 2024. Outset Medical, Inc. (NASDAQ: OM) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Outset Medical, Inc. (NASDAQ: OM) common shares between August 1, 2022 and August 7, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 1, 2022 and August 7, 2024, the Defendants failed to disclose to investors, that the Tablo products were marketed for continuous renal replacement therapy, which is not one of the indications approved by the FDA, that, as a result, Outset Medical was reasonably likely to submit an additional 510(k) application for the Tablo products, that there was a substantial risk that the Company would cease sales of the Tablo products pending FDA approval of additional indications, that Outset Medical lacked the sales team and process to execute on the ramp of Tablo sales, that, as a result of the foregoing, the Company's revenue growth would be adversely impacted, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on October 28th coming up in Lawsuit for Investors in Outset Medical, Inc. (NASDAQ: OM) here
News-ID: 3713052 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of WEBTOON Entertainme …
An investigation on behalf of current long-term investors in shares of WEBTOON Entertainment Inc. (NASDAQ: WBTN) concerning potential breaches of fiduciary duties by certain directors of WEBTOON Entertainment Inc. was announced.
Investors who are current long term investors in WEBTOON Entertainment Inc. (NASDAQ: WBTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
Deadline on Nov. 19th coming up in Lawsuit for Investors who lost money with Dom …
A deadline is coming up on November 19, 2024 in the lawsuit filed for certain investors of Domino's Pizza, Inc. (NYSE: DPZ) over alleged securities laws violations by Domino's Pizza, Inc.
Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ) have certain options and there are strict and short deadlines running. Deadline: November 19, 2024. NYSE: DPZ stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors who lost money with shares of United Parcel Service, …
An investor, who purchased shares of United Parcel Service, Inc. (NYSE: UPS), filed a lawsuit over alleged violations of Federal Securities Laws by United Parcel Service, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of United Parcel Service, Inc. (NYSE: UPS) have certain options and for certain investors are short and strict deadlines running. Deadline: December 9, 2024. NYSE: UPS investors should contact the Shareholders…
Long-Term Investors in shares of Palo Alto Networks, Inc. (NASDAQ: PANW) should …
An investigation was announced for current long-term investors in shares of Palo Alto Networks, Inc. (NASDAQ: PANW) concerning potential breaches of fiduciary duties by certain directors of Palo Alto Networks, Inc.
Investors who are current long term investors in Palo Alto Networks, Inc. (NASDAQ: PANW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current…
More Releases for Outset
Deadline on September 6th coming up in Lawsuit for Investors in Outset Medical, …
A deadline is coming up on September 6, 2022 in the lawsuit filed for certain investors of Outset Medical, Inc. (NASDAQ: OM) over alleged securities laws violations by Outset Medical, Inc. (NASDAQ: OM.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and there are strict and short deadlines running. Deadline: September 6, 2022. NASDAQ: OM stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors in shares of Outset Medical, Inc. (NASDAQ: OM)
An investor, who purchased shares of Outset Medical, Inc. (NASDAQ: OM), filed a lawsuit alleged violations of Federal Securities Laws by Outset Medical, Inc.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 6, 2022. NASDAQ: OM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Jose, CA based Outset…
Investigation announced for Investors in shares of Outset Medical, Inc. (NASDAQ: …
An investigation was announced concerning potential securities laws violations by Outset Medical, Inc. in connection with certain statements.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series…
Dialysis Equipment Market to 2028 |Teleflex Incorporated, B. Braun Melsungen AG, …
Market Research Hub (MRH) has carefully analyzed this research study titled Dialysis Equipment Market: High Demand for Continuous Renal Replacement Therapy Systems to be Observed During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Dialysis Equipment Market.…
Hemodialysis Catheter Market – Utilisation Survey 2025 | Toray Medical Co., Lt …
Global Hemodialysis Catheter Market: Overview
Hemodialysis catheters are being extensively used to meet the growing demand of hemodialysis, apheresis, infusion, and monitoring of central venous pressure along with high-pressure contrast injection patients. It is predominantly used for maintaining effective blood flow rate, which is estimated at 400 ml/min for at least 3 hours. The growing number of patients suffering from end-stage renal disease (ESRD) have increased the demand for hemodialysis to…
Hemodialysis Catheter Market – Global Need Assumptions 2025 | Toray Medical Co …
Hemodialysis Catheter Market: Snapshot
Hemodialysis catheters play a crucial role in the delivery of hemodialysis for renal replacement therapy in patients with end-stage renal diseases. The hemodialysis catheter can be used as a means for making permanent vascular access when access through arteriovenous (AV) fistula or AV graft may not be possible. The catheter is mostly used as tunneled catheter placed under the skin under one of the larger veins, preferably…
